Gw&K Investment Management, LLC Repligen Corp Transaction History
Gw&K Investment Management, LLC
- $11.8 Billion
- Q4 2024
A detailed history of Gw&K Investment Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 92 shares of RGEN stock, worth $12,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92
Previous 92
-0.0%
Holding current value
$12,881
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.06 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$999 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$714 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$237 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$216 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.77B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....